Life Sciences Investors in North America

Album VC is a venture capital firm founded in 2014 (rebranded from Peak Ventures in 2019), headquartered in Lehi, Utah. Focusing exclusively on early-stage technology ventures, Album backs founders building innovative software, SaaS, fintech, healthcare services, life science, and oncology companies with high growth potential. The firm operates with a streamlined team of 2–10 employees, emphasizing close, founder-first partnerships. Since its founding, Album has made nearly 190 investments, including early bets in well-known startups such as Podium, Divvy, Neighbor, Filevine, TaxBit, MX, Andela, and Weave. Album VC III (2020 vintage), its flagship fund, targets software, SaaS, life sciences, healthcare services, TMT, and oncology companies, deploying initial checks typically between $1 million and $1.5 million per company.

Animal Capital is a venture capital firm headquartered in New York City and Los Angeles, California, founded by TikTok influencers including Josh Richards, Griffin Johnson, and Noah Beck. The firm specializes in investing in early-stage companies with a focus on Generation Z consumers, leveraging proprietary marketing channels and social media influence to drive growth and consumer awareness.The firm manages a $15 million fund, Animal Capital Fund I, which primarily targets investments in the consumer products and services, financial technology, health and wellness, and media sectors. Animal Capital invests mainly in the United States, focusing on companies in sectors such as CPG/D2C, Web3/crypto, marketplaces, ecommerce, communications and information technology, and life sciences.Animal Capital typically invests in pre-seed, seed, and Series A rounds, with check sizes ranging from $100K to $1M. The firm combines traditional venture capital services with a unique ability to influence a new generation of consumers through its founders' social media reach. The team includes key partners such as Josh Richards (Founder and Operating Partner), Griffin Johnson (General Partner), Dylann Sands (Partner), and Marshall Sandman (Managing Partner).

Arcline Investment Management is a growth-oriented private equity firm that specializes in investing in technology-driven, industrial businesses. With a focus on sectors such as aerospace and defense, life sciences, energy transition, and specialty materials, Arcline aims to build meaningful companies that contribute to a better future. Founded in 2018, Arcline has rapidly expanded its portfolio, completing numerous platform and add-on acquisitions. The firm's investment strategy centers on partnering with management teams to drive growth and operational excellence in middle-market companies. With offices in Nashville, San Francisco, and New York, Arcline manages approximately $14 billion in assets under management, reflecting its commitment to long-term value creation in critical industries.

Atlas Venture is a leading early-stage venture capital firm based in Cambridge, Massachusetts, specializing in the creation and development of biotech companies. The firm partners with scientific entrepreneurs to translate breakthrough innovations into new therapeutic solutions that address unmet medical needs. By combining deep domain expertise with an entrepreneurial approach, Atlas plays a hands-on role in company formation and growth. Since its founding, Atlas has been instrumental in launching and scaling numerous successful biotechnology startups. The firm provides more than capital—it contributes operational guidance, strategic support, and access to a robust network of advisors, co-investors, and industry leaders. This integrated approach has made Atlas a key player in the biotech ecosystem. Atlas Venture maintains a sharp focus on early-stage investing, often co-founding companies from the ground up. Its portfolio includes a broad range of therapeutic areas including oncology, immunology, neurology, and rare diseases. With its base in the biotech hub of Cambridge, the firm is well-positioned to harness cutting-edge research and talent to fuel innovation globally.

Kleiner Perkins, founded in 1972 by Eugene Kleiner and Tom Perkins, is a renowned venture capital firm based in Menlo Park, California. With a legacy of backing pioneering companies like Amazon, Google, and Genentech, the firm has been instrumental in shaping the technology landscape. Over the decades, Kleiner Perkins has invested in over 900 ventures, focusing on early-stage and growth-stage companies that drive innovation across various sectors. The firm's investment strategy encompasses a broad range of industries, including technology, healthcare, life sciences, and sustainability. Kleiner Perkins is known for its hands-on approach, partnering closely with entrepreneurs to provide not only capital but also strategic guidance and operational support. This collaborative model has led to numerous successful exits, including IPOs and acquisitions, solidifying its reputation as a top-tier venture capital firm. With offices in Menlo Park, San Francisco, and Shanghai, Kleiner Perkins maintains a global presence to support its diverse portfolio. The firm's commitment to fostering groundbreaking ideas and its track record of successful investments continue to attract visionary founders seeking to make a significant impact in their respective industries.

Founded in 2004, Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare and life sciences sectors. The firm specializes in leveraged investments in middle-market companies, aiming to drive growth and create value through strategic partnerships and operational expertise. Linden's investment strategy centers on three core elements: healthcare specialization, integrated private equity and operating expertise, and a differentiated human capital program. This approach enables the firm to identify and cultivate opportunities in medical products, specialty distribution, pharmaceuticals, and healthcare services. With over $13 billion in regulatory assets under management as of April 2025, Linden has invested in more than 45 healthcare companies, encompassing over 350 transactions. The firm's commitment to collaborative partnerships and its Value Creation Program have been instrumental in building strong platforms and thriving businesses within the healthcare industry.

Nina Capital, founded in 2019 and headquartered in Barcelona, is a specialized venture capital firm investing in early‑stage health technology companies with global ambitions. The firm focuses on need‑driven founders building innovations in diagnostics, medical devices, clinician training, healthcare infrastructure, and data‑driven clinical pathways. Initial investments range from €200 000 to €1.5 million, with capital reserved for follow‑on rounds. In early 2025 Nina Capital closed its €50 million Fund III, bringing assets under management to over €100 million. With a portfolio spanning more than 50 companies across Europe, North America, Israel, Canada and Australia, ​the team applies strategic insight, operational hands‑on support, and a Stanford Biodesign‑inspired methodology to help founders scale.

Omega Funds is a global investment firm focused on identifying and supporting transformational companies in the life sciences sector. With a mission to improve human health, Omega Funds primarily invests in biopharmaceuticals, medical technologies, diagnostics, and digital health. The firm backs science-driven innovation and partners with entrepreneurs developing breakthrough products across the U.S. and Europe.Founded in 2004, Omega Funds manages approximately $2 billion in assets under management. Its investment strategy spans early to late-stage private companies, as well as select public market opportunities. Omega’s portfolio includes a wide range of pioneering biotech firms tackling high-impact areas such as oncology, rare diseases, neurodegeneration, and gene therapies.Headquartered in Boston, Massachusetts, with an additional presence in London, Omega Funds has built a reputation for deep sector knowledge, long-term support, and close collaboration with scientific founders. The firm often takes a hands-on approach, contributing to company strategy, governance, and clinical development to help build lasting and valuable businesses.As a specialist life sciences investor, Omega Funds continues to pursue opportunities that align with its vision of delivering meaningful therapeutic innovation. Its global perspective and scientific focus make it a key player in the advancement of next-generation healthcare solutions.

Founded in 2009, Sixth Street is a global investment firm headquartered in San Francisco, California. The firm manages over $110 billion in assets under management and committed capital, offering flexible, long-term capital solutions across various sectors and geographies. Sixth Street operates through diversified investment platforms, including growth equity, direct lending, infrastructure, real estate, and special situations. With a team of more than 650 professionals, including over 280 investment experts, Sixth Street maintains a global presence with offices in key financial centers such as New York, London, Dallas, and Hong Kong. The firm's collaborative culture, known as the "One Team" approach, fosters cross-platform collaboration and innovation, enabling it to identify and capitalize on unique investment opportunities across various sectors and geographies. Sixth Street's diversified investment strategy encompasses a wide range of industries, including technology, healthcare, financial services, sports and media, infrastructure, real estate, agriculture, energy, consumer and retail, industrial services, telecommunications, and entertainment. The firm's commitment to responsible investing and long-term partnerships positions it as a trusted capital partner for businesses seeking strategic growth and transformation.

Sutter Hill Ventures is one of Silicon Valley’s original venture capital firms. Founded in 1964, it has played a formative role in the development of the region’s technology ecosystem for six decades. With approximately US$2.3 billion in assets under management, Sutter Hill focuses on early‑stage investments in enterprise software, infrastructure, cybersecurity, networking and cloud computing. The firm is known for its high‑touch approach: partners often work shoulder‑to‑shoulder with founders, sometimes serving as interim executives or helping incubate companies from the idea stage. Sutter Hill has been behind several transformative businesses, including Pure Storage, Snowflake, NetApp and Lam Research. Its network and institutional memory provide deep insight into cycles of innovation and market adoption. While headquartered in Palo Alto, the firm also maintains an office in London to engage with European entrepreneurs. Sutter Hill differentiates itself by staying invested through multiple rounds, aligning with founders’ long‑term visions and providing access to operational resources, customer introductions and recruiting support. The firm’s longevity and consistent performance have earned it a reputation as a trusted partner to some of the most ambitious technologists.